Earum Pharmaceuticals Limited IPO Details

Our Company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. We offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by us under our own brand name, the manufacturing of which is outsourced by us to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API’s).

Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the key promoters of our company. Our promoters collectively have more than four decades of experience among them. Our Company was originally incorporated as “Earum Pharmaceuticals Private Limited” on July 26, 2012 at Ahmedabad, Gujarat under the provisions of the Companies Act, 1956. On January 23, 2019, our company was converted into a Public Limited Company and consequently the name of our Company was changed from “Earum Pharmaceuticals Private Limited” to “Earum Pharmaceuticals Limited”.
Earum Pharmaceuticals Limited IPO Details
Issue Open 21-06-2019
Issue Close 26-06-2019
Allotment Date 02-07-2019
Unblocked Amount 03-07-2019
Listing Date 04-07-2019
Issue Share 18,48,000 Total Equity Share
96,000 Reserved by Market Maker
17,52,000 Equity Share
Issue Size ₹ 6.65 Cr
IPO Price Band ₹ 36
Minimum Share Bid 3000
Minimum Investment Amount [Rs]  ₹ 1,08,000
Face Value ₹ 10
Retail Allocation 50%
Listing On BSE SME
Earum Pharmaceuticals Limited IPO Grey Market Premium GMP]
Latest Update Premium Kostak Subject to Sauda Recommended
24-06-2019 : 08:00 AM - - - -
Earum Pharmaceuticals Limited IPO Financial details [in Rs, Cr]
Financial Year Total Assets Total Revenue Total Expenses Profit After Tax
FY-2014 - - - -
FY-2015 - - - -
FY-2016 8.79 18.63 18.47 0.09
FY-2017 11.08 23.70 23.45 0.15
FY-2018 20.53 35.85 34.60 0.85
31/12/18 27.42 34.50 33.30 0.86
Earum Pharmaceuticals Limited IPO Valuation Details
Earnings Per Share [EPS] ₹ 3.50
Price/Earnings [P/E] Ratio 10.29
Return on Net Worth [RoNW] 20.34 %
Net Asset Value [NAV] ₹ 136.46 Per Share
Earum Pharmaceuticals Limited IPO Subscription Details
As on Date QIB/NII RII Total
Shared Offered 8,76,000 8,76,000 17,52,000
Day-1 [21-06-2019] 10,14,000 [1.16] 18,000 [0.02] 10,32,000 [0.77]
Day-2 [24-06-2019] 11,31,000 [1.29] 2,19,000 [0.25] 13,50,000 [0.77]
Day-3 [25-06-2019] 12,75,000 [1.46] 5,94,000 [0.68] 18,69,000 [1.07]
Day-4 [26-06-2019] 15,03,000 [1.72] 12,99,000 [1.48] 28,02,000 [1.60]
Earum Pharmaceuticals Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here
Earum Pharmaceuticals Limited IPO Allotment Status
Check Allotment Status :- Click Here
Live Subscription for Earum Pharmaceuticals Limited IPO
Check Live Subscription :- Click Here
Download Earum Pharmaceuticals Limited IPO RHP & ASBA e-Forms
Download RHP :- Click Here to Download
Download e-Forms BSE:- Click Here to Download
Earum Pharmaceuticals Limited IPO Recommendations
Live IPO Team Recommendation:- Neutral
Earum Pharmaceuticals Limited IPO Contact Details
Earum Pharmaceuticals Limited
G1, Ground Floor,
V R Complex,
Near Sanathal Cross Road,
SP Ring Road,
Tel No: +91-79-48402525
E-mail: cs@earumpharma.com
Website: https://www.earumpharma.com
Registrar of Earum Pharmaceuticals Limited IPO
Address:-1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis, Makwana Road,
Marol, Andheri East, Mumbai - 400059
Tel No.:+91-022-62638200Fax No.: +91-022-62638299
Contact Person: Mr. Ashok Shetty
SEBI Regn. No.: INR000001385
Lead Managers of Earum Pharmaceuticals Limited IPO
904,A Wing, Naman Midtown, Senapati Bapat Marg, Elphinstone Road, Lower Parel,
Mumbai-400013, India
Tel. No.: +91- 022- 49060000Fax No.: +91- 022- 22625991
Website: www.hemsecurities.com
Email: ib@hemsecurities.com
Investor Grievance Email: redressal@hemsecurities.com
Contact Person :Mr. Anil Bhargava
SEBI Regn. No. INM000010981
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Earum Pharmaceuticals Limited IPO Details"

Post a Comment